Efgartigimod for the Treatment of Acute Optic Neuritis

NCT06453694 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Optic Neuritis

Interventions

DRUG: Efgartigimod Alfa
DRUG: Placebo

Sponsor

Anastasia Vishnevetsky, MD, MPH

Collaborators

[object Object]